Technology News and Research

RSS

Cielo MedSolutions, DrFirst partner to provide a comprehensive e-prescribing solution

Cielo MedSolutions today announced a new partnership with DrFirst to provide comprehensive e-prescribing functionality to practices using the company's Cielo Clinic clinical quality management system. The fully integrated e-prescribing solution will enable customers to improve prescribing safety and medical practice efficiency.

3 Dec 2009

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

Rules-Based Medicine, Inc. (RBM) today announced that Psynova Neurotech Limited (Cambridge UK), a majority-owned subsidiary of RBM, has executed an exclusive research and licensing agreement with Roche to collaborate on the discovery, development, validation and commercialization of diagnostic immunoassays to aid the clinical development and commercial differentiation of novel treatments for schizophrenia.

3 Dec 2009

China's SFDA initiates quality investigation of Simcere Pharmaceutical Group subsidiary's rabies vaccine

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").

3 Dec 2009

NOXXON Pharma achieves important milestone in drug discovery

NOXXON Pharma AG (NOXXON), the biopharmaceutical company focusing on the development of novel medicines based on its unique proprietary Spiegelmer® technology, announced today the achievement of an important milestone in its drug discovery and development partnership with Eli Lilly and Company.

3 Dec 2009

Positive results from NanoBio's recombinant H5N1 flu antigen-nanoemulsion vaccine combination study

NanoBio Corporation today announced positive results from studies in mice in which immune responses were evaluated following administration of 5µg doses of recombinant H5N1 pandemic flu antigen combined with the company’s novel nanoemulsion vaccine. These studies are unique because the adjuvant was administered for the first time by subcutaneous (SC) and intramuscular (IM) injections.

3 Dec 2009

arGEN-X to develop its SIMPLE Antibody engine with completed EUR 12.5M Series A equity financing

arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody(TM) platform, today announced the successful second closing of its Series A equity financing round. The Company raised an additional EUR 3.0 million (~USD 4.5 million) from two leading life science investors, Credit Agricole Private Equity and VIB (the prestigious Flemish research institute).

3 Dec 2009

MaRS teams up with Baycrest to develop and market brain fitness products

One of the world's leading cognitive science institutes announced today it has created a new company with MaRS, Canada's premiere innovation centre, to develop and market brain fitness products to help adults extend their memory and cognitive abilities longer in the lifespan.

3 Dec 2009

ImmunoCellular Therapeutics options immunotherapy targeting CSCs using abnormal Notch and Numb pathways

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is focused on the development of novel immune-based cancer therapies, announced today that it has entered into an option agreement with The University of Texas M. D. Anderson Cancer Center relating to an immunotherapy targeting cancer stem cells (CSCs) which has demonstrated in pre-clinical animal models significant abilities to target and destroy CSCs.

3 Dec 2009

HHS Secretary announces plans to support innovative Beacon Community Program

HHS Secretary Kathleen Sebelius and Dr. David Blumenthal, HHS’ National Coordinator for Health Information Technology, announced today plans to make available $235 million to support an innovative Beacon Community Program.

3 Dec 2009

Interactive video presentation on corset trunkplasty surgery

Alexander P. Moya, M.D., Director of the Center for Weight Loss Body Contouring and Assistant Director of the Geisinger Center for Aesthetics and Cosmetic Surgery at Geisinger Medical Center (GMC), will deliver an interactive video presentation on his corset trunkplasty surgery in April 2010. This presentation will be made to a group of board-certified plastic surgeons at the American Society for Aesthetic Plastic Surgery's annual Aesthetic Meeting in Washington, D.C.

3 Dec 2009

Specially developed PACEM system installed at Max Planck Institute for Biophysics

PACEM is a transmission electron microscope (TEM) designed to image low-contrast biological specimens. It was specially developed and installed at the Max Planck Institute for Biophysics (MPI-BP) by optical expert Carl Zeiss in Oberkochen and researchers from the Macromolecular Complexes excellence cluster in Frankfurt.

3 Dec 2009

Novel multi-analyte approach to develop urine-biomarker based diagnostic assay to be presented

Predictive Biosciences today announced that Company scientists will be presenting a novel multi-analyte approach to the development of a non-invasive, urine-biomarker based diagnostic assay during the 10th Annual Meeting of the Society of Urologic Oncology (SUO).

3 Dec 2009

LSI collaborates with United Healthcare to meet the growing demand for spinal procedures

Laser Spine Institute (LSI), the leader in minimally invasive spinal surgery, is pleased to announce a partnership with United Healthcare and affiliates after an extensive six-month negotiation and clinical review process.

3 Dec 2009

First computerized crash model to test how crash forces affect the human body

Although states are not required to report fetal deaths in accident data, between 300 and 1,000 unborn babies die in car accidents each year. This accident fatality rate is about four times the rate for victims between infancy and four years old, said Stefan Duma, head of the Virginia Tech --- Wake Forest University School of Biomedical Engineering and Science (SBES).

3 Dec 2009

Bavarian Red Cross selects Microcap portable capnographs for RTW medical vehicles

Oridion Systems Ltd. today announced that the Bavarian Red Cross has chosen Microcap(R) portable capnographs for its RTW (Rettungswagen) medical vehicles.

3 Dec 2009

SJH and Pharos Innovations team up to enhance care and reduce healthcare costs

According to Stephen F. Jencks, MD, MPH, in a recent New England Journal of Medicine article, America's healthcare crisis is fueled by unnecessary and costly hospitalizations, including re-admissions -- 90% of which are unplanned and at a price-tag of $17.4 billion. To enhance care and combat readmissions, South Jersey Healthcare (SJH), a leading regional healthcare provider in southern New Jersey, has entered a partnership with Pharos Innovations that aims to reduce healthcare costs while improving quality of life for patients.

3 Dec 2009

Researchers build better artificial visual systems using high-performance gaming hardware

Taking inspiration from genetic screening techniques, researchers from Harvard and MIT have demonstrated a way to build better artificial visual systems with the help of low-cost, high-performance gaming hardware.

3 Dec 2009

VARI scientists determine the structure of receptors that plants use to sense ABA

Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants respond to environmental stresses such as drought and cold.

3 Dec 2009

AMICAS announces new contract with Washington Radiology Associates

AMICAS, Inc., a leader in image and information management solutions, today announced a new contract with Washington Radiology Associates (Fairfax, VA). This agreement will extend Washington Radiology Associates' long-standing partnership with AMICAS to include AMICAS PACS(TM).

3 Dec 2009

Huntington Memorial Hospital's stroke program receives Gold Seal of Approval

Huntington Memorial Hospital's stroke program has received the Gold Seal of Approval from the Joint Commission, designating the hospital a primary stroke center. This means Huntington will join the network of "approved stroke center" hospitals throughout Los Angeles County.

3 Dec 2009

Technology News and Research

Cielo MedSolutions, DrFirst partner to provide a comprehensive e-prescribing solution

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

China's SFDA initiates quality investigation of Simcere Pharmaceutical Group subsidiary's rabies vaccine

NOXXON Pharma achieves important milestone in drug discovery

Positive results from NanoBio's recombinant H5N1 flu antigen-nanoemulsion vaccine combination study

arGEN-X to develop its SIMPLE Antibody engine with completed EUR 12.5M Series A equity financing

MaRS teams up with Baycrest to develop and market brain fitness products

ImmunoCellular Therapeutics options immunotherapy targeting CSCs using abnormal Notch and Numb pathways

HHS Secretary announces plans to support innovative Beacon Community Program

Interactive video presentation on corset trunkplasty surgery

Specially developed PACEM system installed at Max Planck Institute for Biophysics

Novel multi-analyte approach to develop urine-biomarker based diagnostic assay to be presented

LSI collaborates with United Healthcare to meet the growing demand for spinal procedures

First computerized crash model to test how crash forces affect the human body

Bavarian Red Cross selects Microcap portable capnographs for RTW medical vehicles

SJH and Pharos Innovations team up to enhance care and reduce healthcare costs

Researchers build better artificial visual systems using high-performance gaming hardware

VARI scientists determine the structure of receptors that plants use to sense ABA

AMICAS announces new contract with Washington Radiology Associates

Huntington Memorial Hospital's stroke program receives Gold Seal of Approval

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News